In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dr. Jennifer Ligibel comments on using Fitbits to study exercise patterns among women undergoing breast cancer treatment.

     

Tags: BreastCancer, Exercise

  • Dr. Alessandra Biffi, director of the gene-therapy program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, comments on treatment advances.

     

Tags: Genetics

  • Dr. Erica Mayer comments on liquid biopsies to help treat cancer.

Tags: BreastCancer

  • Doctors at Dana-Farber/Boston Children's Cancer and Blood Disorders Center launched a clinical trial for patients with a rare type of cancer called anaplastic astrocytoma.

Tags: ChildhoodCancer

  • Dr. Jennifer Ligibel is leading a study to see if weight loss should be prescribed as a treatment for breast cancer.

Tags: BreastCancer, Exercise

  • Dana-Farber is leading a national effort with The Broad to encourage patients with metastatic breast cancer to share their medical information.

Tags: BreastCancer

  • Dana-Farber/Boston Children’s Cancer and Blood Disorders Center was ranked highest for treating pediatric cancer in the latest rankings compiled by U.S. News & World Report.

     

Tags: ChildhoodCancer

  • Dr. Jennifer Ligibel comments on Dana-Farber offering complementary therapies to help patients.

  • Dr. Pasi Janne comments on the immunotherapy drug Keytruda for treating patients with non-small cell lung cancer.

Tags: LungCancer, Immunotherapy

  • In a step that could lead to a new diabetes treatment, Dana-Farber has joined several Boston-area hospitals and medical institutions to make personalized cell-based therapies and organize clinical trials.

     

Tags: BasicResearch, TargetedTherapy

Showing 1-10 of 674 items